Search

Your search keyword '"Fernández-Quintero ML"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Fernández-Quintero ML" Remove constraint Author: "Fernández-Quintero ML"
71 results on '"Fernández-Quintero ML"'

Search Results

1. Broadly inhibitory antibodies to severe malaria virulence proteins.

2. Assessing AF2's ability to predict structural ensembles of proteins.

3. AIntibody: an experimentally validated in silico antibody discovery design challenge.

4. On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.

5. Inactivation induced by pathogenic Ca v 1.3 L-type Ca 2+ -channel variants enhances sensitivity for dihydropyridine Ca 2+ channel blockers.

6. Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.

7. Pathogenicity of de novo CACNA1D Ca 2+ channel variants predicted from sequence co-variation.

8. Ca V 1.1 voltage-sensing domain III exclusively controls skeletal muscle excitation-contraction coupling.

9. Fit-for-purpose heterodivalent single-domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile.

10. The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics.

11. Defining the cross-reactivity between peanut allergens Ara h 2 and Ara h 6 using monoclonal antibodies.

12. Broadly inhibitory antibodies against severe malaria virulence proteins.

13. Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain library.

14. Characterization of two pathological gating-charge substitutions in Cav1.4 L-type calcium channels.

15. Addressing Challenges of Macrocyclic Conformational Sampling in Polar and Apolar Solvents: Lessons for Chameleonicity.

16. PEP-Patch: Electrostatics in Protein-Protein Recognition, Specificity, and Antibody Developability.

17. Structural Basis of the Immunological Cross-Reactivity between Kiwi and Birch Pollen.

18. Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines.

19. Cross-linking disulfide bonds govern solution structures of diabodies.

20. Defining and Studying B Cell Receptor and TCR Interactions.

21. Establishing a cell-based screening workflow for determining the efficiency of CYP2C9 metabolism: moving towards the use of breath volatiles in personalised medicine.

22. Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9.

23. Evolution of the Immunoglobulin Isotypes-Variations of Biophysical Properties among Animal Classes.

24. High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein.

25. A novel calcium channel Cavβ 2 splice variant with unique properties predominates in the retina.

26. Structural mechanism of Fab domain dissociation as a measure of interface stability.

27. Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies.

28. Structural Characterization of Nanobodies during Germline Maturation.

29. Challenges in antibody structure prediction.

30. Assessing developability early in the discovery process for novel biologics.

31. pH-dependent structural diversity of profilin allergens determines thermal stability.

32. Calcium current modulation by the γ1 subunit depends on alternative splicing of CaV1.1.

33. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.

34. Comparison of hydrophobicity scales for predicting biophysical properties of antibodies.

35. The Structural Flexibility of PR-10 Food Allergens.

36. Grid inhomogeneous solvation theory for cross-solvation in rigid solvents.

37. Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR.

38. Essential role of a conserved aspartate for the enzymatic activity of plasmanylethanolamine desaturase.

39. Paratope states in solution improve structure prediction and docking.

40. Bispecific antibodies-effects of point mutations on CH3-CH3 interface stability.

41. Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats.

42. Broadly neutralizing antibodies target a haemagglutinin anchor epitope.

43. Explicit solvation thermodynamics in ionic solution: extending grid inhomogeneous solvation theory to solvation free energy of salt-water mixtures.

44. Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats.

45. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.

46. Ion-pair interactions between voltage-sensing domain IV and pore domain I regulate Ca V 1.1 gating.

47. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.

48. Germline-Dependent Antibody Paratope States and Pairing Specific V H -V L Interface Dynamics.

49. Pore mutation N617D in the skeletal muscle DHPR blocks Ca 2+ influx due to atypical high-affinity Ca 2+ binding.

50. Implementation of the Freely Jointed Chain Model to Assess Kinetics and Thermodynamics of Thermosensitive Coil-Globule Transition by Markov States.

Catalog

Books, media, physical & digital resources